Delivery Order SPE2DB24D2101-SPE2DB25FKHJN
Award Date
3/6/25
Potential Completion Date
3/7/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REMIFENTANIL 1 MG VIALS. The contract has a ceiling value of $2,103.90 and is set to expire on July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,917.75, is for the delivery of REMIFENTANIL 2 MG VIALS, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,300.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of REMIFENTANIL 2 MG VIALS, a pharmaceutical product, with a completion date of February 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The order is for the supply of Remifentanil 1 mg vials, with a ceiling value of $6,583.50 and a period of performance through July 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,667.30, is for the delivery of REMIFENTANIL 1 MG VIALS, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,699.97, is for the delivery of 2 mg vials of the drug Remifentanil. The contract has a period of performance through May 24, 2024 and utilizes a Firm Fixed Price pricing type. This Delivery Order is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, valued at $3,640.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 2 mg vials, a specialized medication. This award is a delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This contract award is a delivery order worth $5,696.14 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 28, 2023 and is a firm fixed price arrangement. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $11,001.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of December 31, 2024, is for the delivery of REMIFENTANIL 1 MG VIALS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,637.53 firm fixed-price contract is for the delivery of remifentanil 2 mg vials, a specialty medication used for pain management. The delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...